Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Integrilin (eptifibatide) - Important Safety Information from GlaxoSmithKline as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
14/03/2007
Problem Or Issue:
Please find attached Safety Communication from GlaxoSmithKline in respect of dose of Integrilin (eptifibatide) in patients with moderate renal impairment
« Back
Date Printed: 29/03/2024